UVA-Led Team Awarded Grant to Develop Global Resource Supporting Nurses Caring for Drug-Resistant Tuberculosis

resisttb
23 minutes ago
1 min read

Researchers from the University of Virginia have recently received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are caring for individuals with drug-resistant tuberculosis (DR-TB). These researchers will be collaborating with other professionals at Johns Hopkins University, Boston University, and Harvard University, and working alongside RESIST-TB and the International Union Against Tuberculosis and Lung Disease (The Union) to develop this groundbreaking online platform. Read more here.

Recent Posts

See All

Dr. Max O'Donnell Is Joining The RESIST-TB Steering Committee

RESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! Max is an Associate Professor of Medicine and Epidemiology at Columbia University Irving Medical Center, where h

6-month drug-resistant tuberculosis treatment more effective, cheaper than existing regimens: ICMR study

A six-month oral treatment for MDR-TB, and also specifically rifampicin-resistant, was found to be both more effective and more cost effective when compared to the longer therapies/medications current

This new, one-two punch could knock out drug-resistant TB

A recent study has demonstrated that rifampicin (a frontline antibiotic for TB) when paired with a second compound called AAP-SO 2 , becomes a more powerful treatment in both suppressing TB resistance

Comments